Volume 103, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



We examined whether baseline mortality risk, as a function of child age and site, modified the azithromycin mortality-reduction effect in the (MORDOR) clinical trial. We used the Cox proportional hazards model with an interaction term. Three models were examined representing three sources for the baseline-risk covariate: two using sources external to MORDOR and the third leveraging data within MORDOR. All three models provided moderate evidence for the effect becoming stronger with increasing baseline mortality ( = 0.02, 0.02, and 0.07, respectively) at the rate of approximately 6–12% additional mortality reduction per doubling of baseline mortality. Etiological and programmatic implications of these findings are discussed.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Keenan JD et al., 2018. Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa. N Engl J Med 378: 15831592.
    [Google Scholar]
  2. Oldenburg CE et al., 2020. Mass azithromycin distribution to prevent childhood mortality: a pooled analysis of cluster randomized trials. Am J Trop Med Hyg 100: 691695.
    [Google Scholar]
  3. DHS, 2017. Malawi Demographic and Health Survey 2015–16, Final Report. Available at: https://dhsprogram.com/publications/publication-fr319-dhs-final-reports.cfm. Accessed December 11, 2018.
    [Google Scholar]
  4. DHS, 2016. Tanzania Demographic and Health Survey and Malaria Indicator Survey, 2015–16, Final Report. Available at: https://dhsprogram.com/publications/publication-FR321-DHS-Final-Reports.cfm. Accessed December 11, 2018.
    [Google Scholar]
  5. MICS, 2013. Enquête Démographique et de Santé et à Indicateurs Multiples (EDSN-MICS IV) 2012 (French). Available at: http://mics.unicef.org/surveys. Accessed December 11, 2018.
    [Google Scholar]
  6. Golding N et al., 2017. Mapping under-5 and neonatal mortality in Africa, 2000–15: a baseline analysis for the sustainable development goals. Lancet 390: 21712182.
    [Google Scholar]
  7. Blackwell M, Honaker J, King G, 2017. A unified approach to measurement error and missing data: overview and applications. Soc Meth Res 46: 303341.
    [Google Scholar]
  8. Porco TC et al., 2020. Efficacy of mass azithromycin distribution for reducing childhood mortality across geographic regions. Am J Trop Med Hyg 103: 12911294.
    [Google Scholar]
  9. Porco TC et al., 2009. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302: 962968.
    [Google Scholar]
  10. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE, 2016. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals. Lancet 388: 30273035.
    [Google Scholar]

Data & Media loading...

Supplementary Material

  • Received : 25 Dec 2018
  • Accepted : 23 Jan 2019
  • Published online : 07 Feb 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error